Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Cancers|May 14, 2022
Prognostic Biomarkers for Survival in Nasopharyngeal Carcinoma: A Systematic Review of the LiteratureKazi Anisha Islam, Larry Ka-Yue Chow, Ngar Woon Kam, et al.
Alimentary Pharmacology & Therapeutics|September 10, 2024
Glycaemic control is a modifiable risk factor for hepatocellular carcinoma and liver-related mortality in patients with diabetesXianhua Mao, Ka-Shing Cheung, Jing-Tong Tan, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2025
Compensatory Hypertrophy and Changes of Liver Function after Sequential TACE, SBRT and Immunotherapy (START-FIT) in Unresectable Hepatocellular CarcinomaRyo Wan Lung Yeung, Keith Wan Hang Chiu, Kenneth Sik Kwan Chan, et al.
Gut|April 3, 2024
Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort studyXianhua Mao, Ka Shing Cheung, Jing-Tong Tan, et al.
JHEP Reports : Innovation in Hepatology|October 16, 2025
Disparate patterns of disease time burden in patients with HCC on immunotherapy or tyrosine kinase inhibitorsRex Wan-Hin Hui, Matthew Shing-Hin Chung, Lu Li, et al.
Advances in Radiation Oncology|October 22, 2020
Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell CarcinomaTsz Him So, Sik Kwan Chan, Wing Lok Chan, et al.
American Journal of Clinical Oncology|July 1, 2014
Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)Francis A S Lee, Benny Chung-Ying Zee, Foon Yiu Cheung, et al.
Oncotarget|July 11, 2018
Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT)Connie H M Ho, Chi-Leung Chiang, Francis A S Lee, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 6, 2022
Presence of tumour capsule on contrast-enhanced CT is associated with improved outcomes of stereotactic body radiation therapy in hepatocellular carcinoma patientsSiu Hin Mak, Sean Man Natalie Wong, Wan Hang Keith Chiu, et al.
JAMA Oncology|September 26, 2024
Complete Response to Locoregional Therapy Plus Immunotherapy for Hepatocellular CarcinomaChi Leung Chiang, Kenneth Sik Kwan Chan, Keith Wan Hang Chiu, et al.
Pageof 7